13F

Stock

Corvus Pharmaceuticals, Inc.

CRVS · held by 3 managers

Reported value

$7.95M

Holders

3

+0 new · −0 exited

Holders’ est. mark

$1.04M

Price effect on 1 books still in the name

Largest holder

$4.55M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY617.2K$4.55MHeld
BARCLAYS PLC309.2K$2.28M$1.04MAdded$904.3K
BANK OF AMERICA CORP /DE/152K$1.12MHeld

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.